Track the Hansa Biopharma AB stock price and the full management transaction log of the company, a listed equity based in Finland. Shares trade on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Hansa Biopharma AB has published 13 public disclosures. Market capitalisation: €3.9bn. The latest transaction was filed on 18 August 2026 (Sale). Among the most active insiders: Michael Bologna. All data is free.
13
Insider Decl.
n/a
Thresholds
€2m
6 ops.
Buy Volume
€3m
7 ops.
Sell Volume
39Σ signal
Buys €2m€3m Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
300 shares@ SEK 185.70100.0% of flowAktieISINISIN SE0002148817FI:A001P621-2
13 of 13 declarations
Acerca de Hansa Biopharma AB
Hansa Biopharma AB es una empresa biofarmacéutica centrada en el desarrollo de tratamientos para pacientes con necesidades médicas no cubiertas. Cotiza en la Bolsa de Estocolmo.